Table 5.

Yearly Socioeconomic Burden per Patient in Patients with Bacteremia from 2013 to 2015

Year		CSE			CRE			Enterobacteriaceae
	GDP	Direct Economic Burden	Indirect Economic Burden	Social Economic Burden	Direct Economic Burden	Indirect Economic Burden	Social Economic Burden	Direct Economic Burden	Indirect Economic Burden	Social Economic Burden
2013	7023.2	25,144.9	29,663.2	54,808.1	42,624.6	21,279.3	63,903.9	32,948.4	25,920.4	58,868.8
2014	7584.1	34,747.7	29,352.5	64,100.2	60,490.7	35,038.6	95,529.3	46,032.3	31,845.0	77,877.4
2015	8076.7	31,082.3	31,017.9	62,100.2	45,219.5	48,120.2	93,339.7	39,267.0	40,919.2	80,186.2

Note: All results reported as US $.

Abbreviations: GDP, gross domestic product; CRE, carbapenem-resistant Enterobacteriaceae; CSE, carbapenem-susceptible Enterobacteriaceae.